Clinical Trials Browser

Completed × Neoplasm, Residual × Neoadjuvant Therapy × Clear all

NCT07567573 2026-05-05

retroESGO ov1

11,383 enrolled

Ovarian Neoplasms, Postoperative Complications, Recurrence, Neoplasm, Residual